91 results
424B3
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Nov 23
Prospectus supplement
9:15am
and be unavailable to offset future income tax liabilities, which could adversely affect AMTI’s operating results.
Under Sections 382 and 383 … pre-change tax attributes to offset its post-change taxable income or taxes may be limited. AMTI completed an analysis under Section 382 through
S-4/A
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
in 2036. Realization of these NOLs depends on future income, and there is a risk that AMTI’s existing NOLs could expire unused and be unavailable to offset … to offset its post-change taxable income or taxes may be limited. AMTI completed an analysis under Section 382 through December 31, 2020 and concluded
S-4
4twq1k70qli
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
425
EX-2.1
rqw12bn48q vz
21 Sep 23
Business combination disclosure
4:28pm
8-K
EX-2.1
99quhs
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm